Cajeta, Helen .

HRN: 05-19-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
METRONIDAZOLE 500MG (TAB)
05/18/2026
05/25/2026
ORAL
500mg
TID
S/P NSVD With RMLE And Repair; PID
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines